Novavax and Gavi Reach Settlement on 2021 COVID-19 Vaccine Advance Purchase Agreement
/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) and Gavi, the Vaccine Alliance (Gavi) today announced they have reached a settlement related to the 2021 Advance...
Stay updated with breaking news from Johnc Jacobs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) and Gavi, the Vaccine Alliance (Gavi) today announced they have reached a settlement related to the 2021 Advance...
Novavax and the Vaccine Alliance announced today that they have reached an agreement relating to the Advance Purchase Agreement decided in 2021 concerning Novavax's COVID-19 prototype vaccine . This...
• Investigators immunised over 4800 young children in a trial in Burkina Faso, Kenya, Mali and Tanzania and found on average 78% efficacy in the 5–17-month age group over the first year• To date 25 million doses manufactured and ready for roll-out by
Novavax reports that the transformation plan initiated in 2023 will continue this year, focusing primarily on product delivery, financial performance and portfolio expansion. The company also confirms...
Novavax announced today that the UK Medicines and Healthcare products Regulatory Agency has granted marketing authorization for its Nuvaxovid XBB.1.5. to prevent Covid-19 in people aged 12 and over.'...